Added to YB: 2018-07-26
Pitch date: 2018-07-26
ALBO [bullish]
Albireo Pharma, Inc.
+38.23%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.
Market Cap
$921.1M
Pitch Price
$31.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-6.56
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ALBIREO PHARMA INC ALBO
A summary for this pitch has not been created yet.
Read full article (0 min)